Correction: Inhibition of SMAD3 effectively reduces ADAMTS‑5 expression in the early stages of osteoarthritis

Wei Xiang, Chao Wang, Zhoujun Zhu, Dui Wang, Zhenyu Qiu, Weishan WangBMC 2023 · DOI · OpenAlex

Overview

This publication serves as a formal correction to the article titled "Inhibition of SMAD3 effectively reduces ADAMTS-5 expression in the early stages of osteoarthritis," originally published in BMC Musculoskeletal Disorders. The primary purpose of this notice is to rectify an error in the institutional affiliation of the lead author, ensuring the accuracy of the scientific record.

Context of the Original Research

The original study investigated the molecular mechanisms underlying osteoarthritis (OA), a degenerative joint disease. The research focused on the TGF-beta signaling pathway, specifically the role of SMAD3. The authors demonstrated that inhibiting SMAD3 could reduce the expression of ADAMTS-5 (A Disintegrin and Metalloproteinase with Thrombospondin Motifs 5), an enzyme responsible for the degradation of aggrecan in articular cartilage.

Details of the Correction

Following the initial publication, it was identified that the affiliation for the first author, Dr. Wei Xiang, was incorrectly recorded. The corrected affiliation is: Renmin Hospital of Zhijiang, Yichang, Hubei, China.

The "Check for updates" system ensures that researchers are notified of corrections to the Version of Record.

Importance of Formal Corrections

While affiliation errors are administrative, their correction is vital for several reasons:

  • Institutional Credit: Accurate metadata ensures that Renmin Hospital of Zhijiang receives proper recognition for the research output, which influences funding and institutional rankings.
  • Version of Record Integrity: Formal corrections maintain a transparent audit trail. Rather than silently editing documents, journals use linked notices to preserve the history of the publication.
  • Metadata Accuracy: Correcting the record via unique Digital Object Identifiers (DOIs) ensures that bibliographic databases and indexing services reflect the true origin of the work.
BMC Musculoskeletal Disorders, the journal where the original study and this correction were published.

Conclusion

The original article has been updated to reflect this change. This correction does not impact the scientific findings or conclusions of the research regarding SMAD3 and ADAMTS-5.

Summary updated

BibTeX
@inproceedings{xiang2023correction,
  author = {Wei Xiang and Chao Wang and Zhoujun Zhu and Dui Wang and Zhenyu Qiu and Weishan Wang},
  title = {{Correction: Inhibition of SMAD3 effectively reduces ADAMTS‑5 expression in the early stages of osteoarthritis}},
  booktitle = {BMC},
  year = {2023},
  doi = {10.1186/s12891-023-06262-8},
}
Figure